Zymography analysis revealed that the activity of MMP-2 and MMP-9 were decreased upon treatment of EGCG in mouse lung carcinoma cells, reinforcing its potential as an anti-cancer agent as shown in Table 4 [110,111]. The gene discussed is MMP2; the disease is cancer.